This site is intended for health professionals only
Tuesday 22 January 2019
Share |

Topic: europe

April 25, 2018
<p>Most European countries had not implemented pricing and reimbursement policies specific to orphan medicines, a study reveals</p>

There are differences in the availability of orphan medicines between European countries, a study has found.

 

Orphan medicines are pharmaceutical products developed specifically for the treatment, prevention or diagnostics of rare diseases, which affect some 30 million people in Europe.

 

Factors limiting the availability of orphan medicines include them not entering the markets, or their financial burden on patients or society being too high.

 

October 5, 2017
Synthon’s three-times-a-week glatiramer acetate is a therapeutically equivalent version of the originator medicine Copaxone® 40mg.

Synthon has announced that it has successfully concluded the decentralised procedures for glatiramer acetate 40mg/ml pre-filled syringe for the treatment of relapsing forms of multiple sclerosis and received regulatory approval in Europe.

 

Synthon received regulatory clearance in all 27 EU/EEA member states involved in the procedures. Granting of national marketing authorizations will follow in the near future.
 

October 10, 2016
Calling all European pharmacists working in gastroenterology and/or hepatology (including IBD and viral hepatitis) to discuss and share practice, provide support in training needs and establish network opportunities.

April 28, 2016
LONSURF demonstrated 2-month improvement in median overall survival (OS) compared to placebo in patients with advanced metastatic colorectal cancer (mCRC) an important benefit in a disease with a 5-year survival rate of only 11% at diagnosis

LONSURF demonstrated 2-month improvement in median overall survival (OS) compared to placebo in patients with advanced metastatic colorectal cancer (mCRC)1,2 an important benefit in a disease with a 5-year survival rate of only 11% at diagnosis.3

 

May 6, 2009
BIA welcomes EU vote on animal testing as old directive is revised

teaser

March 4, 2009
Pfizer begins selling generic drugs throughout the US and Europe

teaser

March 4, 2009
Annual report 2008 - Lundbeck meets all of its financial forecasts for 2008 and expects continuing growth in 2009

teaser

December 16, 2008
Consultation paper opens talks on how to improve healthcare services across the EU

teaser

July 3, 2008
The European Commission adopts proposed directive for patients' rights in cross-border healthcare

teaser

June 11, 2008
Bangladeshi pharmaceutical company moves to market generics in Europe

teaser

April 30, 2008
European Commission grants full approval of HIV protease inhibitor

teaser

March 25, 2008
Multiple sclerosis therapy natalizumab should come with a warning of potentially higher risk of liver damage, EU regulators say

teaser

January 1, 2008
Demand for transplant organs Europe-wide is hardly being met, with donor numbers at just 0.8

teaser

November 29, 2007
Former Soviet states had the largest number of new HIV infections last year in the European region, according to an EU report

teaser

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine